This is not surprising as TNBCs have been previously annotated to contain greater amounts of tumour infiltrating lymphocytes and immunotherapies have shown greatest efficacy in this subtype, while ER+ tumours are generally considered immunologically ‘cold’.32, 33, 34. This evidence concerns the gene ESR1 and neoplasm.